- Home
- SKY vs PTGX Comparison
SKY vs PTGX Comparison
Compare SKY & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKY
- PTGX
- Stock Information
- Founded
- SKY 2010
- PTGX 2006
- Country
- SKY United States
- PTGX United States
- Employees
- SKY N/A
- PTGX N/A
- Industry
- SKY Homebuilding
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- SKY Consumer Discretionary
- PTGX Health Care
- Exchange
- SKY Nasdaq
- PTGX Nasdaq
- Market Cap
- SKY 3.6B
- PTGX 5.0B
- IPO Year
- SKY N/A
- PTGX 2016
- Fundamental
- Price
- SKY $82.95
- PTGX $79.54
- Analyst Decision
- SKY Buy
- PTGX Strong Buy
- Analyst Count
- SKY 2
- PTGX 9
- Target Price
- SKY $85.00
- PTGX $86.22
- AVG Volume (30 Days)
- SKY 867.5K
- PTGX 1.3M
- Earning Date
- SKY 11-04-2025
- PTGX 11-06-2025
- Dividend Yield
- SKY N/A
- PTGX N/A
- EPS Growth
- SKY 48.48
- PTGX N/A
- EPS
- SKY 3.84
- PTGX 0.72
- Revenue
- SKY $2,624,539,000.00
- PTGX $209,217,000.00
- Revenue This Year
- SKY $5.10
- PTGX N/A
- Revenue Next Year
- SKY $4.21
- PTGX $140.23
- P/E Ratio
- SKY $21.62
- PTGX $110.44
- Revenue Growth
- SKY 12.14
- PTGX N/A
- 52 Week Low
- SKY $59.44
- PTGX $33.31
- 52 Week High
- SKY $116.49
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- SKY 64.83
- PTGX 62.21
- Support Level
- SKY $64.45
- PTGX $75.44
- Resistance Level
- SKY $68.44
- PTGX $80.43
- Average True Range (ATR)
- SKY 3.46
- PTGX 2.61
- MACD
- SKY 1.09
- PTGX -0.23
- Stochastic Oscillator
- SKY 98.77
- PTGX 89.38
About SKY Skyline Champion Corporation
Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.